围产期心肌病64例临床特点及治疗分析

摘要

Objective:To observe the clinical features of patients with peripartum cardiomyopathy and analyze the curative effect.Methods:Sixty four patients with peripartum cardiomyopathy who came to our hospital were divided into two groups randomly:control group and treatment group.The control group accepted conventional therapy,such as oxygen uptake,diuresis,vasodilator reflex,anti thrombus and anti congestive heart failure.Based on the control group,the treatment group accepted telmisartan and pulse-activating injection.The course of treatment was four weeks.The treatmenet effect and heart function of two groups was compared.Results:The curative effect of treatment group was better than that of control group(P＜0.05).The heart function parameter post-treatment was much better than that of control group(P＜0.05).Conclusions:Telmisartan and pulse-activating injection can improve the heart function of patients with peripartum cardiomyopathy and has significant therapeutic effect.%目的:观察围产期心肌病患者的临床特点,分析治疗效果.方法:选择我院收治的64例围产期心肌病患者为研究对象,随机分为2组:对照组和治疗组.对照组:给予吸氧、利尿、扩血管、防血栓,抗心力衰竭等常规治疗;治疗组:在对照组治疗的基础上,给予替米沙坦和生脉注射液,疗程4周.比较2组患者的疗效及心功能变化.结果:治疗组患者的疗效明显优于对照组(P＜0.05);治疗后心功能各参数均优于对照组(P＜0.05).结论:替米沙坦联合生脉注射液可改善围产期心肌病患者的心功能,疗效显著.